Home
>
National Drug Code (NDC)
>
Daliresp
Daliresp - 0456-0095-90 - (roflumilast)
Drug Information of Daliresp
| Product NDC: | 0456-0095 |
| Proprietary Name: | Daliresp |
| Non Proprietary Name: | roflumilast |
| Active Ingredient(s): | 500 ug/1 & nbsp; roflumilast |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Daliresp
| Product NDC: | 0456-0095 |
| Labeler Name: | Forest Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022522 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110228 |
Package Information of Daliresp
| Package NDC: | 0456-0095-90 |
| Package Description: | 90 TABLET in 1 BOTTLE, PLASTIC (0456-0095-90) |
NDC Information of Daliresp
| NDC Code | 0456-0095-90 |
| Proprietary Name | Daliresp |
| Package Description | 90 TABLET in 1 BOTTLE, PLASTIC (0456-0095-90) |
| Product NDC | 0456-0095 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | roflumilast |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110228 |
| Marketing Category Name | NDA |
| Labeler Name | Forest Laboratories, Inc. |
| Substance Name | ROFLUMILAST |
| Strength Number | 500 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes |
